The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,922.00
Bid: 2,760.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 167.00 (6.051%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,922.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Action Capital Markets Seminar & portfolio update

24 Mar 2022 07:00

RNS Number : 8317F
3i Group PLC
24 March 2022
 

 

 

24 March 2022

 

3i Group plc

Action Capital Markets Seminar and portfolio update 

3i will be holding a capital markets seminar this morning, involving a presentation from the management team of Action, our largest portfolio company. A live webcast of the seminar will take place at 10.00 (UK time). To register for the webcast, please visit https://www.3i.com/investor-relations. An on-demand webcast of the seminar will also be available on our website by the end of the day.

 

Action performed strongly in 2021, generating net sales of €6,834 million (up 23% on the previous year) and EBITDA of €828 million (a 36% increase on the previous year). Reported like-for-like sales growth was 11%, even though many stores were closed or had restricted trading as a result of public health measures. The business added 267 net new stores to its portfolio and expanded its presence into the Italian market. Action has seen a good start to 2022 across all its geographies. More details on Action's performance will be available in the presentation.

 

We completed our semi-annual portfolio company review ("PCR") meetings for our top 20 Private Equity investments (which at 31 December accounted for 97% of the total Private Equity portfolio value) during the two weeks commencing 7 March 2022. Overall, the PCR meetings re-emphasised the strong momentum in the portfolio as it emerges from the pandemic, with particularly good performance from our healthcare and consumer retail assets. Inflation and supply chain challenges will be a focus this year and the majority of companies in our portfolio have plans to mitigate these issues.

 

3i Group has no direct exposure to Russia or Ukraine. We are reviewing our Private Equity and Infrastructure companies to understand the situation across the portfolio. Our initial review indicates that exposure is minimal, although one company has an operating subsidiary in Russia and that company is exploring how best to deal with the situation in the short term. Action has not been directly impacted and has no stores in that region.

 

3i will be donating £1 million split between UNICEF and MSF in support of humanitarian relief efforts to aid victims of the war in Ukraine. A number of our portfolio companies, including Action, have also made donations or otherwise provided support to those affected by the war.

 

- Ends -

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

Notes to editors:

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com.

 

 

About Action

Action (www.company.action.com) is the fastest growing non-food discounter in Europe, offering an ever changing variety of approx. 6000 products in 2000 stores to more than 11 million customers every week. In addition, each week another 8 million consumers visit the Action.com website. Action employs over 65,000 people in 9 countries with over 130 different nationalities. While offering a constantly surprising assortment at the lowest prices, Action continues to improve its products in terms of quality and sustainability.

 

 

Action's annual results press release and Annual Update are now available on www.company.action.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOSRRUWUOUUR
Date   Source Headline
6th Apr 201710:47 amRNSDirector Declaration
31st Mar 20171:50 pmRNSTotal Voting Rights
31st Mar 20171:50 pmRNSDirector/PDMR Shareholding
6th Mar 20179:45 amRNSDirector/PDMR Shareholding
3rd Mar 201710:00 amRNSCompletion of sale of 3i Debt Management
28th Feb 20172:30 pmRNSTotal Voting Rights
28th Feb 20172:26 pmRNSDirector/PDMR Shareholding
31st Jan 20174:21 pmRNSTotal Voting Rights
31st Jan 20174:21 pmRNSDirector/PDMR Shareholding
26th Jan 20177:00 amRNSQ3 performance update
25th Jan 20179:14 amRNSAdditional Listing
6th Jan 20174:23 pmRNSPortfolio Update
30th Dec 201611:52 amRNSTotal Voting Rights
30th Dec 201611:49 amRNSDirector/PDMR Shareholding
12th Dec 20162:14 pmRNSBlock listing Interim Review
30th Nov 20163:13 pmRNSTotal Voting Rights
30th Nov 20163:12 pmRNSDirector/PDMR Shareholding
22nd Nov 20162:10 pmRNSDirector/PDMR Shareholding
11th Nov 201612:48 pmRNSDirector/PDMR Shareholding
10th Nov 20162:02 pmRNSDoc re. 2016 Half Yearly Report
10th Nov 20167:00 amRNSHalf-year Report
31st Oct 20161:13 pmRNSTotal Voting Rights
31st Oct 20161:11 pmRNSDirector/PDMR Shareholding
25th Oct 20167:00 amRNSAgreement to sell Debt Management business
5th Oct 20163:13 pmRNSPortfolio Update
3rd Oct 20161:45 pmRNSDirector/PDMR Shareholding
30th Sep 20162:20 pmRNSTotal Voting Rights
30th Sep 20162:18 pmRNSDirector/PDMR Shareholding
22nd Sep 201610:39 amRNSDirector Declaration
7th Sep 20169:33 amRNSDirectorate Change
7th Sep 20169:30 amRNSInterest in bond buy-backs
31st Aug 20162:00 pmRNSTotal Voting Rights
31st Aug 20161:56 pmRNSDirector/PDMR Shareholding
9th Aug 20163:07 pmRNSDirector/PDMR Shareholding
9th Aug 20162:24 pmRNSDirector/PDMR Shareholding
4th Aug 201610:21 amRNSPurchase of Notes
2nd Aug 201611:58 amRNSDirector/PDMR Shareholding
29th Jul 20163:31 pmRNSTotal Voting Rights
29th Jul 20163:25 pmRNSDirector/PDMR Shareholding
28th Jul 20161:11 pmRNSDirector/PDMR Shareholding
27th Jul 20167:00 amRNSFY2017 Q1 Performance update
4th Jul 201611:40 amRNSPortfolio Update
30th Jun 20163:16 pmRNSResult of AGM
30th Jun 20163:12 pmRNSDoc re. AGM Resolutions
30th Jun 20163:11 pmRNSDirector/PDMR Shareholding
30th Jun 20162:50 pmRNSTotal Voting Rights
30th Jun 20162:46 pmRNSDirector/PDMR Shareholding
30th Jun 20167:10 amRNSAnnual General Meeting
30th Jun 20167:00 amRNSUpdate on Action valuation
13th Jun 20162:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.